Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balances at Dec. 31, 2023	$ 361	$ 276,393	$ (308,819)	$ (32,065)
Balances (in shares) at Dec. 31, 2023	36,122,932
Exercise of stock options		42		42
Exercise of stock options (in shares)	13,407
Withholdings for taxes related to net share settlement of equity awards, shares	(4,222)
Stock-based compensation expense		534		534
Net loss			(25,021)	(25,021)
Balances at Mar. 31, 2024	$ 361	276,969	(333,840)	(56,510)
Balances (in shares) at Mar. 31, 2024	36,132,117
Balances at Dec. 31, 2024	$ 362	279,354	(327,735)	(48,019)
Balances (in shares) at Dec. 31, 2024	36,183,067
Issuance of common stock upon release of restricted stock units, net of tax withholdings		(14)		(14)
Issuance of common stock upon release of restricted stock units, net of tax withholdings (In shares)	10,412
Stock-based compensation expense		781		781
Net loss			(6,531)	(6,531)
Balances at Mar. 31, 2025	$ 362	$ 280,121	$ (334,266)	$ (53,783)
Balances (in shares) at Mar. 31, 2025	36,193,479